Article Versions Notes

Bafiti V, Ouzounis S, Chalikiopoulou C, Grigorakou E, Grypari IM, Gregoriou G, Theofanopoulos A, Panagiotopoulos V, Prodromidi E, Cavouras D, et al. A 3-miRNA Signature Enables Risk Stratification in Glioblastoma Multiforme Patients with Different Clinical Outcomes. Current Oncology. 2022; 29(6):4315-4331. https://doi.org/10.3390/curroncol29060345

Bafiti, Vivi, Sotiris Ouzounis, Constantina Chalikiopoulou, Eftychia Grigorakou, Ioanna Maria Grypari, Gregory Gregoriou, Andreas Theofanopoulos, Vasilios Panagiotopoulos, Evangelia Prodromidi, Dionisis Cavouras, and et al. 2022. "A 3-miRNA Signature Enables Risk Stratification in Glioblastoma Multiforme Patients with Different Clinical Outcomes" Current Oncology 29, no. 6: 4315-4331. https://doi.org/10.3390/curroncol29060345

Bafiti, V., Ouzounis, S., Chalikiopoulou, C., Grigorakou, E., Grypari, I. M., Gregoriou, G., Theofanopoulos, A., Panagiotopoulos, V., Prodromidi, E., Cavouras, D., Zolota, V., Kardamakis, D., & Katsila, T. (2022). A 3-miRNA Signature Enables Risk Stratification in Glioblastoma Multiforme Patients with Different Clinical Outcomes. Current Oncology, 29(6), 4315-4331. https://doi.org/10.3390/curroncol29060345